Newsfeeds - Spark Newswire

1 minute read

Legal
News

VYNE Therapeutics Files For U.S. Patent Titled ‘USE OF NEUROKININ-1 ANTAGONISTS TO TREAT PRURITUS’

Today, 4:22 AM

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210169848%22.PGNR.&OS=DN/20210169848&RS=DN/2021

VYNE

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 4:22 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

6 minute read

Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline

Today, 4:22 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

5 minute read

Uncategorized

72 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:22 AM

Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume.

AGFY

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 4:22 AM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI

Latest news

VYNE Therapeutics Files For U.S. Patent Titled ‘USE OF NEUROKININ-1 ANTAGONISTS TO TREAT PRURITUS’

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

72 Biggest Movers From Yesterday

Earnings Scheduled For May 6, 2021